Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue...

Published on 7 Nov 2024 on GuruFocus.com · via Yahoo Finance

Coherus BioSciences Inc (CHRS) reports significant revenue growth and market share gains, despite...

Read the rest of the article

Start tracking your investments with Statfolio

Coherus BioSciences Inc (CHRS) reports significant revenue growth and market share gains, despite...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Coherus BioSciences Inc (NASDAQ:CHRS) is set to release its Q3 2024 earnings on Nov 6, 2024. The...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Total Revenue: $65 million, a 10% increase year-over-year.UDENYCA Revenue: $50.9 million, a 19% i...

GuruFocus.com · via Yahoo Finance 6 Oct 2024

We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sell...

Insider Monkey · via Yahoo Finance 29 Sep 2024

Key Insights Coherus BioSciences to hold its Annual General Meeting on 29th of MaySalary of US$98...

Simply Wall St. via Yahoo Finance 23 May 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript May 10, 2024. CHRS isn't...

Insider Monkey via Yahoo Finance 10 May 2024

With the business potentially at an important milestone, we thought we'd take a closer look at Co...

Simply Wall St. via Yahoo Finance 8 May 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript March 13, 2024 Coherus B...

Insider Monkey via Yahoo Finance 16 Mar 2024

Net Revenue: Coherus BioSciences Inc (NASDAQ:CHRS) reported a significant increase in net revenue...

GuruFocus.com via Yahoo Finance 13 Mar 2024

Key Insights Institutions' substantial holdings in Coherus BioSciences implies that they have sig...

Simply Wall St. via Yahoo Finance 5 Mar 2024